Stacie-Ann Sammott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stacie-Ann Sammott has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Aisha Lofters
Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
2 shared publications - Bryan Maguire
Biostatistics Design and Analysis Unit, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
2 shared publications - Cynthia Nguyen
Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada
2 shared publications - Elizabeth Ey Choi
Research Department, RxFood Corporation, Toronto, ON, Canada
2 shared publications - Jeffrey Alfonsi
Research Department, RxFood Corporation, Toronto, ON, Canada
2 shared publications - Jennifer Nan Stinson
Research Institute, The Hospital for Sick Children
2 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by University of Toronto Libraries - UOTL in University of Toronto Journal of Public Health
- Vol. 7 (3)
Evaluating the Healthcare Experiences and Unmet Needs of Black Women with Metastatic Breast Cancer: A Narrative Review
Background: Breast cancer remains the most diagnosed cancer among women worldwide. Black women experience higher mortality rates, are more often diagnosed at advanced stages, and face persistent structural barriers to timely and equitable care. In the context of metastatic breast cancer, these inequities become even more pronounced. Despite this, the lived experiences and unmet care needs of Black women with metastatic disease have not been comprehensively synthesized. This narrative review examines the international literature to better understand these experiences and to identify ongoing gaps in care. Methods: A comprehensive search strategy was developed using OVID Medline and conducted across twelve databases. Peer-reviewed studies published in English that focused on the experiences, perceptions, or care needs of Black women with metastatic breast cancer were included. Editorials, commentaries, and studies not specific to metastatic disease were excluded. Three independent reviewers screened studies at the title, abstract, and full-text stages. Two reviewers completed data extraction and thematic synthesis. Results: Sixty studies met inclusion criteria; most originated from the United States, with additional studies from Canada, the United Kingdom, and several African countries. The included literature was comprised of qualitative studies, quantitative analyses, mixed-methods research, and clinical observational studies. Six interrelated themes emerged: cultural competence, personal beliefs and healthcare trust, healthcare navigation, discrimination and bias, support systems, and financial burden. Across studies, Black women described challenges rooted in structural inequities, limited culturally responsive care, healthcare system complexity, and experiences of discrimination. Conclusion: The experiences of Black women with metastatic breast cancer are shaped by intersecting structural and interpersonal barriers that influence care access, treatment experiences, and support. Evidence remains limited outside of the United States and parts of Africa. Further research is needed to more fully understand these disparities and to inform interventions that address the unmet needs of Black women living with metastatic disease.
- 10 July 2026
- Published by University of Toronto Libraries - UOTL in University of Toronto Journal of Public Health
- Vol. 7 (3)
Open AccessEvaluating the Healthcare Experiences and Unmet Needs of Black Women with Metastatic Breast Cancer: A Narrative Review
Background: Breast cancer remains the most diagnosed cancer among women worldwide. Black women experience higher mortality rates, are more often diagnosed at advanced stages, and face persistent structural barriers to timely and equitable care. In the context of metastatic breast cancer, these inequities become even more pronounced. Despite this, the lived experiences and unmet care needs of Black women with metastatic disease have not been comprehensively synthesized. This narrative review examines the international literature to better understand these experiences and to identify ongoing gaps in care. Methods: A comprehensive search strategy was developed using OVID Medline and conducted across twelve databases. Peer-reviewed studies published in English that focused on the experiences, perceptions, or care needs of Black women with metastatic breast cancer were included. Editorials, commentaries, and studies not specific to metastatic disease were excluded. Three independent reviewers screened studies at the title, abstract, and full-text stages. Two reviewers completed data extraction and thematic synthesis. Results: Sixty studies met inclusion criteria; most originated from the United States, with additional studies from Canada, the United Kingdom, and several African countries. The included literature was comprised of qualitative studies, quantitative analyses, mixed-methods research, and clinical observational studies. Six interrelated themes emerged: cultural competence, personal beliefs and healthcare trust, healthcare navigation, discrimination and bias, support systems, and financial burden. Across studies, Black women described challenges rooted in structural inequities, limited culturally responsive care, healthcare system complexity, and experiences of discrimination. Conclusion: The experiences of Black women with metastatic breast cancer are shaped by intersecting structural and interpersonal barriers that influence care access, treatment experiences, and support. Evidence remains limited outside of the United States and parts of Africa. Further research is needed to more fully understand these disparities and to inform interventions that address the unmet needs of Black women living with metastatic disease.
- Open Access
- 21 March 2024
- Published by Elsevier in Cancer Epidemiology
- Vol. 90, 102562
Stage of diagnosis and survival for prostate cancer among immigrant men in Ontario, Canada
- 21 March 2024
- Published by Elsevier in Cancer Epidemiology
- Vol. 90, 102562
Open AccessStage of diagnosis and survival for prostate cancer among immigrant men in Ontario, Canada
- Open Access
- 28 October 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (10) , e22074
Carbohydrate Counting App Using Image Recognition for Youth With Type 1 Diabetes: Pilot Randomized Control Trial
Background: Carbohydrate counting is an important component of diabetes management, but it is challenging, often performed inaccurately, and can be a barrier to optimal diabetes management. iSpy is a novel mobile app that leverages machine learning to allow food identification through images and that was designed to assist youth with type 1 diabetes in counting carbohydrates. Objective: Our objective was to test the app's usability and potential impact on carbohydrate counting accuracy. Methods: Iterative usability testing (3 cycles) was conducted involving a total of 16 individuals aged 8.5-17.0 years with type 1 diabetes. Participants were provided a mobile device and asked to complete tasks using iSpy app features while thinking aloud. Errors were noted, acceptability was assessed, and refinement and retesting were performed across cycles. Subsequently, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included levels of engagement and acceptability. Change in HbA1c level was also assessed. Results: Use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA1c levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges were identified. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study. Conclusions: Our results provide evidence of efficacy and high acceptability of a novel carbohydrate counting app, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management. Trial Registration: ClinicalTrials.gov NCT04354142; https://clinicaltrials.gov/ct2/show/NCT04354142
- 28 October 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (10) , e22074
Open AccessCarbohydrate Counting App Using Image Recognition for Youth With Type 1 Diabetes: Pilot Randomized Control Trial
Background: Carbohydrate counting is an important component of diabetes management, but it is challenging, often performed inaccurately, and can be a barrier to optimal diabetes management. iSpy is a novel mobile app that leverages machine learning to allow food identification through images and that was designed to assist youth with type 1 diabetes in counting carbohydrates. Objective: Our objective was to test the app's usability and potential impact on carbohydrate counting accuracy. Methods: Iterative usability testing (3 cycles) was conducted involving a total of 16 individuals aged 8.5-17.0 years with type 1 diabetes. Participants were provided a mobile device and asked to complete tasks using iSpy app features while thinking aloud. Errors were noted, acceptability was assessed, and refinement and retesting were performed across cycles. Subsequently, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included levels of engagement and acceptability. Change in HbA1c level was also assessed. Results: Use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA1c levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges were identified. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study. Conclusions: Our results provide evidence of efficacy and high acceptability of a novel carbohydrate counting app, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management. Trial Registration: ClinicalTrials.gov NCT04354142; https://clinicaltrials.gov/ct2/show/NCT04354142
- Open Access
- 2 July 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Carbohydrate Counting App Using Image Recognition for Youth With Type 1 Diabetes: Pilot Randomized Control Trial (Preprint)
BACKGROUND Carbohydrate counting is an important component of diabetes management, but it is challenging, often performed inaccurately, and can be a barrier to optimal diabetes management. iSpy is a novel mobile app that leverages machine learning to allow food identification through images and that was designed to assist youth with type 1 diabetes in counting carbohydrates. OBJECTIVE Our objective was to test the app's usability and potential impact on carbohydrate counting accuracy. METHODS Iterative usability testing (3 cycles) was conducted involving a total of 16 individuals aged 8.5-17.0 years with type 1 diabetes. Participants were provided a mobile device and asked to complete tasks using iSpy app features while thinking aloud. Errors were noted, acceptability was assessed, and refinement and retesting were performed across cycles. Subsequently, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included levels of engagement and acceptability. Change in HbA1c level was also assessed. RESULTS Use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA1c levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges were identified. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study. CONCLUSIONS Our results provide evidence of efficacy and high acceptability of a novel carbohydrate counting app, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management. CLINICALTRIAL ClinicalTrials.gov NCT04354142; https://clinicaltrials.gov/ct2/show/NCT04354142
- 2 July 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCarbohydrate Counting App Using Image Recognition for Youth With Type 1 Diabetes: Pilot Randomized Control Trial (Preprint)
BACKGROUND Carbohydrate counting is an important component of diabetes management, but it is challenging, often performed inaccurately, and can be a barrier to optimal diabetes management. iSpy is a novel mobile app that leverages machine learning to allow food identification through images and that was designed to assist youth with type 1 diabetes in counting carbohydrates. OBJECTIVE Our objective was to test the app's usability and potential impact on carbohydrate counting accuracy. METHODS Iterative usability testing (3 cycles) was conducted involving a total of 16 individuals aged 8.5-17.0 years with type 1 diabetes. Participants were provided a mobile device and asked to complete tasks using iSpy app features while thinking aloud. Errors were noted, acceptability was assessed, and refinement and retesting were performed across cycles. Subsequently, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included levels of engagement and acceptability. Change in HbA1c level was also assessed. RESULTS Use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA1c levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges were identified. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study. CONCLUSIONS Our results provide evidence of efficacy and high acceptability of a novel carbohydrate counting app, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management. CLINICALTRIAL ClinicalTrials.gov NCT04354142; https://clinicaltrials.gov/ct2/show/NCT04354142